Here are three key facts to know.
1. The company hopes to raise $115 million from the IPO.
2. The proceeds will be used to fund the continued commercialization of its Fuse endoscopy system, according to the report.
3. The company’s stock closed at $17.10 per share Wednesday.
More articles on gastroenterology:
Physicians Endoscopy acquires Garden State Endoscopy Center: 4 insights
CDC: CME course for colonoscopy
6 things to know about female GI physician leadership
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.